US
VanEck Pharmaceutical ETF
PPH · Equity
$101
+1.48%
Assets
n/a
Expense ratio
0.36%
Holdings
26
1Y return
+22.0%
Forward P/E
n/a
Top 10 holdings
+73.1%
Return and risk
| 1Y total return | +22.0% |
| 3Y total return | +36.3% |
| 5Y total return | +57.4% |
| 3Y CAGR | +10.9% |
| 5Y CAGR | +9.5% |
| Beta | 0.46 |
| RSI | 46.81 |
Fund structure
| Asset class | Equity |
| Assets | n/a |
| Holdings | 26 |
| Expense ratio | 0.36% |
| Dividend yield | +2.1% |
| Top 10 holdings | +73.1% |
| Volume | 475.3K |
All ETF indicators
| All Time High | 112.58 |
| All Time High Change | -10.14 |
| All Time High Date | 2026-02-17 |
| All Time Low | 35.42 |
| All Time Low Change | 185.67 |
| All Time Low Date | 2011-12-21 |
| Atr | 1.56 |
| Beta | 0.46 |
| Cagr10y | 7.94 |
| Cagr1y | 22.03 |
| Cagr3y | 10.88 |
| Cagr5y | 9.5 |
| Ch10y | 77.68 |
| Ch1m | -2.56 |
| Ch1w | -1.4 |
| Ch1y | 19.3 |
| Ch3m | -8.27 |
| Ch3y | 28.37 |
| Ch5y | 42.94 |
| Ch6m | 3.02 |
| Ch YTD | -1.94 |
| Close | 99.69 |
| Div CAGR10 | 4.47 |
| Div CAGR3 | 14.82 |
| Div CAGR5 | 14.03 |
| Dividend Growth | 26.72 |
| Dividend Growth Years | 3 |
| Dividend Years | 15 |
| Dividend Yield | 2.13 |
| Dps | 2.15 |
| Ex Div Date | 2026-04-01 |
| High52 | 112.58 |
| High52ch | -10.14 |
| High52 Date | 2026-02-17 |
| Inception Date | 2000-02-01 |
| Isin | US92189F6925 |
| Last Dividend | 0.84 |
| Low52 | 81.74 |
| Low52ch | 23.77 |
| Low52 Date | 2025-08-07 |
| Ma150 | 102.09 |
| Ma150ch | -0.9 |
| Ma20 | 101.45 |
| Ma200 | 98.55 |
| Ma200ch | 2.66 |
| Ma20ch | -0.28 |
| Ma50 | 103.02 |
| Ma50ch | -1.8 |
| Payment Date | 2026-04-07 |
| Payout Frequency | Quarterly |
| Payout Ratio | 39.23 |
| Price Date | 2026-05-12 |
| Rsi | 46.81 |
| Rsi Monthly | 58.15 |
| Rsi Weekly | 48.94 |
| Sharpe Ratio | 0.99 |
| Sortino Ratio | 1.94 |
| Top10holdings | 73.09 |
| Tr10y | 114.67 |
| Tr1m | -2.56 |
| Tr1y | 22.01 |
| Tr3m | -7.52 |
| Tr3y | 36.31 |
| Tr5y | 57.45 |
| Tr6m | 4.18 |
| Tr YTD | -1.14 |